Valneva SE is a vaccine company focused on developing life-saving vaccines... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VALN is expected to report earnings to rise 47.87% to -44 cents per share on March 19
Q4'25
Est.
$-0.45
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.22
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
The last earnings report on November 13 showed earnings per share of -30 cents, beating the estimate of -33 cents. With 8.93K shares outstanding, the current market capitalization sits at 751.77M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VALN showed earnings on November 13, 2025. You can read more about the earnings report here.